门静脉4级血栓接受肾静脉-门静脉吻合式肝移植1例报道  

A case report of reno-portal anastomosis liver transplantation for grade 4 portal vein thrombosis

作　　者：刘忠忠 钟自彪[1] 薛承彪[1] 周威 叶少军[1] 叶啟发[1] Liu Zhongzhong;Zhong Zibiao;Xue Chenbiao;Zhou Wei;Ye Shaojun;Ye Qifa(Institute of Hepatobiliary Diseases,Zhongnan Hospital of Wuhan University,National Quality Control Center for Donated Organ Procurement,Transplant Center of Wuhan University,Hubei Key Laboratory of Medical Technology on Transplantation,Wuhan 430071,China)

机构地区：[1]武汉大学中南医院肝胆疾病研究院、国家人体捐献器官获取质量控制中心、武汉大学移植医学中心、移植医学技术湖北省重点实验室,武汉430071

出　　处：《中华器官移植杂志》2024年第4期265-268,共4页Chinese Journal of Organ Transplantation

基　　金：国家自然科学基金项目(81970548);湖北省自然科学基金项目(2021CFB046)。

摘　　要：本研究回顾1例2022年5月19日门静脉4级血栓肝移植受者在武汉大学中南医院接受肾静脉-门静脉吻合(reno-portal anastomosis,PRA)式肝移植的临床资料。受者PRA式肝移植术后2周内转氨酶和胆红素恢复正常水平,术后5~7天肌酐出现轻度增高,随后很快恢复,术后2年内未发生门静脉血栓、消化道出血、腹水等并发症,随访生存良好。The relevant clinical data were reviewed for a recipient of grade 4 portal vein thrombus undergoing reno-portal anastomosis liver transplantation on May 19,2022.Liver function transaminase and bilirubin gradually normalized within 2 weeks after operation.An elevation of creatinine showed mild functional impairment at Day 5-7 post-operation and then recovered quickly.No portal vein thrombosis,gastrointestinal hemorrhage,ascites and other complications occurred within 2 years post-operation.The survival was excellent during 2-year follow-ups.

关 键 词：肝移植 门静脉血栓 疗效 

分 类 号：R657.3[医药卫生—外科学]